24 May 2013
Keywords: isogenica, signs, peptide, deal, wyeth, cambridge, uk-based
Article | 11 June 2007
Cambridge, UK-based Isogenica has entered into a research and licensing agreement with US drug major Wyeth. Under the terms of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 June 2007
18 June 2007
4 June 2007
© 2013 thepharmaletter.com